PATENT CLAIM ANALYSIS

Application Number: 15540344
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to a hybrid-type multi-lamellar nanostructure of an epidermal growth factor and a liposome and a method for manufacturing same. The new type of hybrid-type multi-lamellar nanostructure not only has a high epidermal growth factor encapsulating efficiency, but also can be manufactured through a simple process, such that the same can be easily delivered into a living body or a cell while maintaining a high physiological activity of the epidermal growth factor.

Claim (Index 8):
The method of  claim 7 , wherein the empty unilamellar liposomes obtained in step (1) have a particle size of 100-300 nm.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.51923
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15253307', '15023052', '13900969', '10617734', '12101107']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588716226132873
- 35 USC 102 Novelty (BERT): 0.511477307946621
- Combined Prediction Score: 0.7341321911466206
- Mean Citation Score: 236.96408
- Max Citation Score: 246.89343
- Similarity Product: 154.88256773442689

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test